wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33590407-06EB434D-D8A3-41CA-B802-8E32E69FD885
Q33590407-06EB434D-D8A3-41CA-B802-8E32E69FD885
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33590407-06EB434D-D8A3-41CA-B802-8E32E69FD885
Sorafenib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study.
P2860
Q33590407-06EB434D-D8A3-41CA-B802-8E32E69FD885
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33590407-06EB434D-D8A3-41CA-B802-8E32E69FD885
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b5b347caa1026dfe7d98b84df812de9bcb70cef3
P2860
Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma.